Riesgo de carcinoma hepatocelular en pacientes con hepatitis crónica VHC y fibrosis en estadio 3 tras respuesta virológica sostenida / Risk of hepatocellular carcinoma in patients with chronic hepatitis c infection and stage 3 fibrosis after sustained virological response
Rev. esp. enferm. dig
; 114(6): 309-311, junio 2022. tab
Article
in Es
| IBECS
| ID: ibc-205647
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Antiviral Agents
/
Hepatitis C
/
Carcinoma, Hepatocellular
/
Liver Cirrhosis
Limits:
Humans
Language:
Es
Journal:
Rev. esp. enferm. dig
Year:
2022
Type:
Article